Injury risk for matched front and rear seat car passengers by injury severity and crash type : an exploratory study

Background: The risk of serious injury or death has been found to be reduced for some front compared to rear seat car passengers in newer vehicles. However, differences in injury severity between car occupants by seating position has not been examined. This study examines the injury severity risk for rear compared to front seat car passengers. Method: A retrospective matched-cohort analysis was conducted of vehicle crashes involving injured rear vs front seat car passengers identified in linked police-reported, hospitalisation and emergency department (ED) presentation records during 2001-2011 in New South Wales (NSW), Australia. Odds ratios were estimated using an ordinal logistic mixed model and logistic mixed models. Results There were 5419 front and 4588 rear seat passengers in 3681 vehicles. There was a higher odds of sustaining a higher injury severity as a rear-compared to a front seat car passenger, with a higher odds of rear seat passengers sustaining serious injuries compared to minimal injuries. Where the vehicle occupant was older, travelling in a vehicle manufactured between 1990 and 1996 or after 1997, where the airbag deployed, and where the vehicle was driven where the speed limit was ≥70 km/h there was a higher odds of the rear passenger sustaining a higher injury severity then a front seated occupant. Conclusion: Rear seat car passengers are sustaining injuries of a higher severity compared to front seat passengers travelling in the same vehicle, as well as when travelling in newer vehicles and where the front seat occupant is shielded by an airbag deployed in the crash. Rear seat occupant protective mechanisms should be examined. Pre-hospital trauma management policies could influence whether an individual is transported to a hospital ED, thus it would be beneficial to have an objective measure of injury severity routinely available in ED records. Further examination of injury severity between rear and front seat passengers is warranted to examine less severe non-fatal injuries by car seating position and vehicle intrusion.9 page(s

Targeting a mimotope vaccine to activating FcγFc\gamma receptors empowers dendritic cells to prime specific CD8+CD8^{+} T cell responses in tumor-bearing mice

A major challenge for inducing antitumor immune responses with native or modified tumor/self-Ags in tumor-bearing hosts relates to achieving efficient uptake and processing by dendritic cells (DCs) to activate immune effector cells and limit the generation of regulatory T cell activity. We analyzed the ability of therapeutic DC vaccines expressing a CD166 cross-reactive mimotope of the GD2 ganglioside, 47-LDA, to selectively expand adoptively transferred, tumor-specific T cells in NXS2 neuroblastoma tumor-bearing syngeneic mice. Before the adoptive cell transfer and DC vaccination, the tumor-bearing mice were lymphodepleted by nonmyeloablative total body irradiation or a myeloablative regimen that required bone marrow transplantation. The 47-LDA mimotope was presented to DCs either as a linear polypeptide in conjunction with universal Th epitopes or as a fusion protein with the murine IgG2a Fc fragment (47-LDA-Fcγ2a) to deliver the antigenic cassette to the activating Fcγ receptors. We demonstrate that immunization of adoptively transferred T cells in tumor-bearing mice with the 47-LDA mimotope expressed in the context of the activating Fc fusion protein induced higher levels of antitumor immune responses and protection than the 47-LDA polypeptide-DC vaccine. The antitumor efficacy of the therapeutic 47-LDA-Fcγ2a-DC vaccine was comparable to that achieved by a virotherapy-associated cancer vaccine using a recombinant oncolytic vaccinia virus expressing the 47-LDA-Fcγ2a fusion protein. The latter treatment, however, did not require total body irradiation or adoptive cell transfer and resulted in induction of antitumor immune responses in the setting of established tolerance, paving the way for testing novel anticancer treatment strategies

Voltammetry assisted by multivariate analysis as a tool for speciation of metallothioneins: competitive complexation of α- and β-metallothionein domains with cadmium and zinc

8 pages, 8 figures, 1 table.-- PMID: 14717171 [PubMed].-- Printed version published Dec 15, 2003.Multivariate Curve Resolution by Alternating Least Squares (MCR-ALS) is applied to voltammetric data obtained in the study of competitive complexation of Zn(II) and Cd(II) by α- and β-domains of metallothionein (MT). The application of MCR-ALS allows the estimation of both the voltammograms and the concentration profiles associated with each electrochemical process. The complexity of the voltammograms obtained in titrations of the α- or β-domains of MT with Cd(II) and later Zn(II) (or vice versa) prevents their direct interpretation using traditional electrochemical methods. But when MCR-ALS is applied, voltammograms can be interpreted rather satisfactorily in both qualitative and quantitative terms. MCR-ALS showed the formation of Cd2Znβdom and Cd3Znαdom complexes when both metals were competitively added. A method based on the combined use of voltammetry and some chemometric techniques is proposed. It can be useful for the metal speciation of environmentally relevant natural ligands.Financial support from the Spanish Ministerio de Ciencia y Tecnología (project BQU2000-0642-C03) and from the Generalitat of Catalonia (2001SGR-00056).Peer reviewe